Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells

NCT03690011 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

T-cell Acute Lymphoblastic Lymphoma
T-non-Hodgkin Lymphoma
T-cell Acute Lymphoblastic Leukemia

Interventions

GENETIC: CD7.CAR/28zeta CAR T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]